ScholarIQanswers from OpenAlex & ORCID
Priya Vart
ResearcherPublications, citations & collaboration network
Priya Vart is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Priya Vart have?
ScholarIQindexed works
Priya Vart has 202 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Priya Vart have?
ScholarIQcitation count
Priya Vart has 27,332 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Priya Vart?
ScholarIQh-index
Priya Vart has an h-index of 47 in OpenAlex.
What is the i10-index of Priya Vart?
ScholarIQi10-index
Priya Vart has an i10-index of 94 in OpenAlex.
What is the ORCID of Priya Vart?
ScholarIQorcid
The ORCID for Priya Vart is on the source record.
What is the OpenAlex record for Priya Vart?
ScholarIQopenalex
The OpenAlex for Priya Vart is on the source record.
What are the most-cited papers on Priya Vart?
ScholarIQmost cited works
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
Luuk B. Hilbrands, Raphaël Duivenvoorden, Priya Vart, Casper Franssen, Marc H. Hemmelder, Kitty J. Jager, Lyanne M. Kieneker, Marlies Noordzij, Michelle J. Pena, Hanne de Vries, David Arroyo, Adrian Covic, Marta Crespo, Éric Goffin, Mahmud İslam, Ziad A. Massy, Núria Montero, João Oliveira, Ana Roca Muñoz, J. Emilio Sánchez-Álvarez, Sivakumar Sridharan, Rebecca Winzeler, Ron T. Gansevoort, ERACODA Collaborators, Jeroen B. van der Net, Marie Essig, Peggy W G du Buf-Vereijken, Betty van Ginneken, Nanda Maas, Liffert Vogt, Brigit C. van Jaarsveld, Fréderike J. Bemelman, Farah Klingenberg-Salahova, Frederiek Heenan‐Vos, Marc Vervloet, Azam Nurmohamed, Daniel Abramowicz, Sabine Verhofstede, Omar Maoujoud, Jana Fialová, Edoardo Melilli, Àlex Favà, Josep M. Cruzado, Joy Lips, Maaike Hengst, Ryszard Gellert, Andrzej Rydzewski, Daniela G Alferes, Ivan Rychlík, Elena Zakharova, Patrice Max Ambuehl, Fanny Lepeytre, Clémentine Rabaté, Guy Rostoker, Sofia Marques, Tijana Azaševac, Dajana Katičić, Marc ten Dam, Thilo Krüger, S. J. J. Logtenberg, Lutz Fricke, Adriaan L Zanen, Jeroen J P Slebe, Delphine Kemlin, Jacqueline van de Wetering, Jaromír Eiselt, Lukáš Kielberger, Hala S El-Wakil, Samar Abd ElHafeez, C Canal, Carme Facundo, Ana Ramos, Alicja Dębska‐Ślizień, Nicoline M H Veldhuizen, Stylianos Panagoutsos, Irina Matceac, Ionuţ Nistor, Monica Cordos, J H M Groeneveld, Marjolijn van Buren, Fritz Diekmann, Ana Cristina Fernandes Maria Ferreira, Augusto César Soares dos Santos, Carlos Arias-Cabrales, Laura Llinàs-Mallol, Anna Buxeda, Carla Burballa Tàrrega, Dolores Redondo‐Pachón, María Dolores Arenas Jiménez, Julia M. Hofstra, Antonio Franco, María Luisa Rodríguez, Sagrario Balda Manzanos, Gabriel de Arriba, R. Haridian Sosa Barrios, Karlijn Bartelet, Erol Demir, Daan A M J Hollander, Angèle P. M. Kerckhoffs, Stefan Büttner
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Ziad A. Massy, Alexander R. Rosenkranz, Ivan Rychlík, María José Soler, Kate Stevens, Roser Torrá, Serhan Tuğlular, Christoph Wanner, Ron T. Gansevoort, ERACODA Working Group, Raphaël Duivenvoorden, Casper Franssen, Marc H. Hemmelder, Luuk B. Hilbrands, Kitty J. Jager, Marlies Noordzij, Priya Vart, Ron T Gansevoort
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Brendon L. Neuen, Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott, Julianna de Oliveira Costa, Michael O. Falster, Sallie‐Anne Pearson, Kenneth W. Mahaffey, Bruce Neal, Rajiv Agarwal, George L. Bakris, Vlado Perkovic, Scott D. Solomon, Muthiah Vaduganathan